As the second leading cause of death worldwide, cancer is a focal point in both clinical research and health care fields, but not all cancers are created equal. While some cancers are now much less deadly due to recent medical advances, other aggressive cancers remain highly resistant to currently available therapies.
This therapy resistance is a leading cause of cancer-associated death. Pancreatic cancer is an extreme example of this effect, and therapy resistance is a major reason why only 4 percent of patients with pancreatic cancer are still alive five years after their diagnosis. Read more . . .